The self-renewal capacity ascribed to embryonic stem cells (ESC) is reminiscent of cancer cell proliferation, raising speculation that a common network of genes may regulate these traits. A search for general regulators of these traits yielded a set of microRNAs for which expression is highly enriched in human ESCs and liver cancer cells (HCC) but attenuated in differentiated quiescent hepatocytes. Here, we show that these microRNAs promote hESC self-renewal, as well as HCC proliferation, and when overexpressed in normally quiescent hepatocytes, induce proliferation and activate cancer signaling pathways. Proliferation in hepatocytes is mediated through translational repression of Pten, Tgfbr2, Klf11, and Cdkn1a, which collectively dysregulates the PI3K/AKT/mTOR and TGFb tumor suppressor signaling pathways. Furthermore, aberrant expression of these miRNAs is observed in human liver tumor tissues and induces epithelial-mesenchymal transition in hepatocytes. These findings suggest that microRNAs that are essential in normal development as promoters of ESC self-renewal are frequently upregulated in human liver tumors and harbor neoplastic transformation potential when they escape silencing in quiescent human hepatocytes. Mol Cancer Res; 10(7); 979-91. Ó2012 AACR.
Introduction
Human embryonic stem cells (hESC) are derived from the inner cell mass of the blastocyst stage of development, characterized by a unique capacity for indefinite self-renewal while maintaining an ability to differentiate into specialized cells (1) . In early mammalian development, the transition from ESCs to various cell fate lineages is carefully orchestrated by the loss of molecular programs governing the maintenance of pluripotency and self-renewal, and activation of new programs specific for lineage determining cells. The switch from self-renewing to quiescent cellular status is particularly evident during liver morphogenesis when ESCs differentiate into quiescent hepatocytes (2) . Because 70% to 80% of the cytoplasmic liver mass is composed of hepatocytes, much attention has been focused on directing the differentiation of hESCs into hepatocytes in vitro, in an effort to generate cells suitable for replacing damaged liver tissue in patients with acute liver failure or chronic end-stage liver disease. While the past decade has witnessed a growing body of literature having showed a significant methodologic progress for enriching hepatocyte-like derivatives from hESCs (3, 4) , an efficient method for evaluating the safety of these derivatives for therapeutic applications remains largely unexplored.
The safety of hESCs and their derivatives is an important concern in regenerative medicine. Although the extensive self-renewal capacity ascribed to hESCs is a major asset as an abundant source of pluripotent cells for use in tissue replacement, their reminiscence to cancer cell proliferation has raised concerns about the tumorigenic risk of stem cells and their derivatives in transplanted tissues (5, 6) . The apparent parallels between stem cell self-renewal and cancer cell proliferation have led to speculation that a common network of genes may regulate these traits and that tight control of these genes during the lineage specification process of pluripotent stem cells into quiescent cellular lineages is critical for avoiding tumor formation (7) (8) (9) (10) (11) (12) (13) . However, to date, it remains unclear whether genes that are essential in normal development as promoters of ESC self-renewal are pervasively upregulated in cancer cells and whether a failure to attenuate the expression of these genes in normal quiescent differentiated cell types may give rise to neoplastic transformation.
In this study, we examined whether microRNAs (miRNA) that are highly expressed in hESCs, as well as liver cancer cells (HCC) play an important role in normal development as promoters of ESC self-renewal and whether a failure to attenuate the expression of these genes in quiescent human primary hepatocytes (hPH) may induce proliferation and activation of cancer signaling pathways. miRNAs are noncoding endogenous regulatory RNAs that refine and limit the expression of mRNAs posttranscription by suppressing translation and influencing the ultimate proteome (14, 15) . These RNAs are particularly useful for evaluating whether ESC self-renewal promoting genes may possess neoplastic transformation potential in differentiated quiescent cell types because recent reports have shown that miRNAs are essential in normal development as promoters of ESC self-renewal (16) . Although a plethora of literature has described the vital regulatory role of this family of RNAs in a wide array of cellular programming, including embryonic development and cancer initiation (17, 18) , whether ESC self-renewal promoting miRNAs are upregulated in HCCs and whether they harbor neoplastic transformation potential in differentiated quiescent human hepatocytes remain unexplored.
Here, we show that miRNAs commonly enriched in hESCs and HCCs promote self-renewal and proliferation and that aberrant expression of these RNAs in normally quiescent human hepatocytes induces proliferation and activates cancer signaling pathways. We show that proliferation in hepatocytes is mediated through direct translational repression of Pten, Klf11, Tgfbr2, and Cdkn1a, which collectively dysregulates the PI3K/AKT/mTOR and TGFb tumor suppressor signaling pathways. Moreover, our analysis shows that these miRNAs induce epithelial-mesenchymal transition (EMT) when aberrantly expressed in hPHs. In human liver tumor tissues, these miRNAs are highly expressed. These findings suggest that ESC self-renewal promoting miRNAs are frequently upregulated in HCCs and that they harbor neoplastic transformation potential when they escape silencing in human hepatocytes. For this reason, tracking the loss of miRNAs that promote ESC self-renewal during the in vitro differentiation process of hESCs into hepatocytes is highly important as one possible measure of safety and efficacy for therapeutic applications.
Materials and Methods

Cell culture and differentiation
Human ESCs. The human H1 and H9 ES cell lines were obtained from the WiCell Research Institute (Madison, WI; WA09) and maintained as a monolayer in 6-well (9.6-cm 2 ) plates on g-irradiated mouse embryonic fibroblast (MEF) feeder layers in Dulbecco's Modified Eagle's Medium (DMEM):Ham's F-12 medium (Invitrogen) supplemented with 20% KnockOut Serum Replacement (Invitrogen), 4 ng/mL basic fibroblast growth factor (Invitrogen), 1 mmol/L nonessential amino acids (Invitrogen), 2 mmol/L L-glutamine (Invitrogen), 100 U/mL penicillin/streptomycin (Invitrogen), and 0.55 mmol/L 2-mercaptoethanol (Invitrogen).
Human induced pluripotent stem cells. Human induced pluripotent stem cells were generated from IMR90 cells following the method described by Takahashi and colleagues (19, 20) .
Mouse ESCs. Mouse v6.5 C57BL/6 and Dgcr8 null ES cells were obtained from Open Biosystems. The cells were maintained as a monolayer on 6-well (9.6-cm 2 ) plates on g-irradiated MEF feeder layers in DMEM (Invitrogen) supplemented with 15% FBS (Hyclone), 1,000 U/mL leukemia-inhibitory factor (Millipore), 1 mmol/L nonessential amino acids (Invitrogen), 2 mL L-glutamine (Invitrogen), and 0.01 mmol/L 2-mercaptoethanol (Invitrogen).
Human primary hepatocytes. hPHs were obtained from the Liver Tissue Procurement and Distribution System at the University of Pittsburgh (Pittsburgh, PA). Upon receiving the cells, they were washed 3 times in PBS without calcium and magnesium and maintained in the HCM Bullet Kit (Lonza).
Hepatocellular carcinoma cells. HepG2 and Hep3B cells (American Type Culture Collection) were cultured per the manufacturer's instructions. Huh7 was a gift from Mark Feitelson at Thomas Jefferson University (Philadelphia, PA) and cultured in the same manner as HepG2 and Hep3B cells.
mRNA and miRNA expression microarrays mRNA arrays. RNA samples were isolated using the Qiagen RNeasy Kit (Qiagen). Before array experiments, the quality of the RNA samples was assayed using the Agilent Systems Bioanalyzer 2100. The total RNA from each sample was biotinylated and amplified for hybridization to Illumina Sentrix Expression BeadChip HumanRef-8 v3.0. This array platform consists of 8 parallel strips, each strip composed of 24,500 probes from the NCBI RefSeq database (Build 36.2, Release 22). Arrays were processed and scanned per the manufacturer's instruction and analyzed using the BeadStudio Software v3.0. All signals were normalized, log 2 -transformed, and ranked according to the log 2 values. For each gene, the criteria for enrichment were set at log 2 value of 7.0 or higher. Hierarchical clustering was conducted with average linkage and Pearson correlation. To generate the heatmap, values were centered and normalized to a mean of 0 and an SD of 1.
miRNA arrays. miRNA samples were isolated using the Qiagen miRNeasy Mini Kit (Qiagen). The purified miRNA samples were labeled with Hy5 fluorophores using the miRCURY LNA microRNA Power Labeling Kit (Exiqon) and hybridized to miRCURY LNA Array v.10 (Exiqon). The processed arrays were scanned at 10-mm resolution using the GenePix 400B Scanner (Axon Instruments). The raw data were normalized, log 2 -transformed, and ranked according to the log 2 values.
DAVID analysis
Functional annotation clusterings were conducted using the DAVID Bioinformatics Resources 2010. Gene sets that were common between HCCs and hESCs, and HCCs and hPHs, were subjected to separate clustering analyses. Each gene set was entered into DAVID's functional annotation clustering tool, which generated clusters of genes on the basis of the similarity of the functional terms assigned to each gene. The clusters were then ranked according to the EASE scores of each term, and the 12 highest ranked clusters were selected for analysis. Within each cluster, the Gene Ontology (GO) term with the lowest P value was selected as a representative functional term.
Lentivirus vector constructs and virus production
The sense and antisense oligonucleotides of precursor miRNAs were annealed and cloned into the plasmid pLVTHM (Addgene #12247) between the MluI and ClaI Figure 1 . miRNAs regulate ESC self-renewal and HCC proliferation. A, images of hESCs and HCCs 36 hours after siDgcr8 or mock siRNA transfection. HCCs are stained with Hoechst 33342. B, hESCs and HCCs were evaluated for self-renewal and proliferation 36 hours after siDgcr8 or mock siRNA transfection using an MTT-based assay. For all statistical analyses, n ¼ 3, error bars represent SEM, and the Student t-test results are indicated ( Ã , P < 0.05) relative to the control. C, images of wild-type mESCs (mESCs WT Genes that scored a differential value of 1 or greater were categorized as differentially upregulated, and genes that scored a value of À1 or less were categorized as differentially downregulated. The scale bar across the top of the heatmap depicts SD change from the mean.
restriction sites under the H1 promoter. A control vector pLVTHM was designed with a scrambled oligonucleotide sequence as described in the work of Xu and colleagues (21) . All vectors were verified by sequencing. Lentivirus production and tittering were carried out following protocols from Trono lab (http://tronolab.epfl.ch).
Quantitative RT-PCR For mRNA quantitative real-time PCR (qRT-PCR), total RNA was isolated using the Qiagen RNeasy Kit (Qiagen), and SuperScript III RT-qPCR Kit (Invitrogen) was used to synthesize cDNAs. For miRNA qRT-PCR, miRNAs were isolated using miRNeasy Mini Kit (Qiagen), and reverse-transcribed into cDNAs using miR-CURY LNA First Strand cDNA Kit (Exiqon). For both mRNAs and miRNAs, qRT-PCR mixture was prepared using either ABI TaqMan or SYBR Master Mix (ABI), and qRT-PCR was carried out on the ABI PRISM 7700 Sequence Detection System (ABI). The comparative 2 ÀDDC t method was used to determine the relative quantitative levels of mRNAs using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for mRNA normalization and Exiqon's Endogenous Control Primers (Exiqon) for miRNA normalization and expressed in values as relative difference compared with the relevant controls.
Luciferase reporter construct and assay
The luciferase reporter was constructed by PCR-amplifying the 3 0 -untranslated regions (UTR) of human Cdkn1a, Pten, Klf11, and Tgfbr2 from the bacterial artificial clones (BAC); RP11-265F6, RP11-846G17, RP11-51D2, and RP11-179K2 (BAC/PAC Resources, http://bacpac.chori. org). The amplicons were cloned into the pMIR-REPORT firefly luciferase plasmid. All vectors were verified by sequencing. Twenty thousand Dgcr8-knockout mESCs were cultured on 48-well plates for 48 hours and co-transfected with firefly luciferase reporter plasmids with the 3 0 UTR inserts and Renilla luciferase reporter plasmids as a normalization control and either miRNA mimics (Qiagen) or mock molecules (Ambion) using Lipofectamine 2000 (Invitrogen). Cells were lysed 36 hours posttransfection and processed for luciferase assays using the Luciferase Dual Reporter Assay System (Promega).
Western blots
Seventy-two hours after the hPHs were transduced with lentivirus, the cells were lysed using the RIPA Lysis and Extraction Buffer (Pierce Biotechnology). The protein concentration was estimated by the BCA Protein Assay Kit (Pierce Biotechnology), and the protein lysates were separated on a 10% gradient SDS-PAGE. Cell proliferation assay mESCs DDgcr8/DDgct8 . Ten thousand Dgcr8-null mESCs were grown on 48-well plates and transfected with 50 pmol of miRNA mimic molecules or mock precursor molecules (Qiagen) using Lipofectamine 2000 (Invitrogen) 24 hours after initial plating of the cells. Four days later, cell proliferation assay was measured using the Cell Titer Cell Proliferation Assay (Promega) at 570-nm absorbance.
HCCs. Ten thousand HepG2, Hep3B, and Huh7 cells were grown on 48-well plates and transfected with 50 pmol of siDgcr8 or siControl mock molecules (Ambion) using Lipofectamine 2000 (Invitrogen) 24 hours after initial plating of the cells. Cell proliferation was measured 48 hours later using the Cell Titer Cell Proliferation Assay (Promega) at 570-nm absorbance.
Hoechst staining
Ten thousand HepG2, Hep3B, and Huh7 cells were grown on 12-well plates and transfected with 100 pmol of siDgcr8 (Ambion) or mock molecules (Ambion) using Lipofectamine 2000 (Invitrogen) 24 hours after initial plating of the cells. Another 48 hours later, HCCs were stained with 5 mmol/L of Hoechst 33342.
Results
miRNAs regulate hESC self-renewal and HCC proliferation
As a starting point of our study, we sought to determine whether miRNAs are involved in regulating hESC selfrenewal and HCC proliferation. To do this, an RNAbinding protein, DGCR8, which is required for the biogenesis of all canonical miRNAs (22, 23) , was transiently knocked down in hESCs and HCC using an RNA interference strategy. Using this approach, we observed a significant decrease in self-renewal and proliferation in hESCs and HCCs ( Fig. 1A-C) . Pearson correlation analysis of global gene expression patterns between the control and the Dgcr8 knockdown conditions revealed a minor change in gene expression patterns subsequent to the depletion of miRNAs in these cells (Fig. 1D) . In Supplementary Fig. S1 , we provide Pearson correlation analyses of all cell samples evaluated before the Dgcr8 knockdown. An evaluation of up-and downregulated genes in hESCs and HCCs following the knockdown of Dgcr8 uncovered 2,713 differentially downregulated genes and 2,220 differentially upregulated genes (Fig. 1E) . GO analysis of differentially downregulated genes revealed the enrichment of genes with functional descriptions associated with general cellular processes (Table 1) , whereas a large fraction of genes that are differentially upregulated possess GO functional terms describing cell-cycle regulation (mitotic cell cycle, regulation of cellcycle process, and G 1 -S transition of mitotic cycle; Table 2 ). These findings suggest that miRNAs may play a role as promoters of hESC self-renewal and HCC proliferation by suppressing a common network of genes that may function as negative regulators of cell-cycle progression in these 2 classes of cells.
A subset of miRNAs commonly enriched in hESCs and HCCs promotes ESC self-renewal
Having shown that miRNAs may play a role as promoters of hESC self-renewal and HCC proliferation, we sought to determine whether miRNAs that are commonly enriched in these 2 classes of cells are involved in controlling these traits. To identify miRNAs that are highly enriched in hESCs and HCCs, but the expressions are either lost or severely attenuated in quiescent hPHs, global miRNA expression profiles were established for hESCs, HCCs, and hPHs. Using this approach, we identified 8 miRNAs (miR-106a, -106b, -18a, -18b, -17, -93, -301a, and -130b) that are highly expressed in both hESCs and HCCs at a level at least 2-fold greater than hPHs ( Fig. 2A and B) . We then used a modified version of a previously reported screening strategy (16) for determining the self-renewal promoting capacity of miRNAs using mESCs with a homozygous deletion of Dgcr8 ( Fig. 2C and D) . This approach allowed us to determine that 6 miRNAs (miR-106a, -106b, -17. -19, -301a, and -130b), among the 8 miRNAs evaluated, were capable of rescuing the self-renewal deficiency in Dgcr8-null mESCs (Fig. 2E) . For brevity, these 6 miRNAs will be referred to as embryonic and HCC miRNAs (EHCC miRNAs). The transient knockdown of the endogenous expressions of EHCC miRNAs in hESCs and HCCs using antagomiRs decreased self-renewal and proliferation (Fig. 2F ). These observations show that miRNAs that play an important role in normal development as promoters of ESC self-renewal are co-opted by HCCs to facilitate proliferation. Interestingly, EHCC miRNAs were not capable of rescuing hepatic lineage specification during the directed differentiation process of Dgcr8-null mESCs along a hepatic lineage in vitro (Supplementary Figs. S2A-S2C and S3A). Taken together, these findings suggest that the primary function of EHCC miRNAs in normal development is to promote ESC self-renewal and that in HCCs, the same set of miRNAs is highly expressed and functions as facilitators of uncontrolled proliferation.
EHCC miRNAs induce proliferation in hPHs
We next sought to determine whether EHCC miRNAs are capable of inducing proliferation in normally quiescent hPHs. To do this, we used lentivirus to mediate the expression of EHCC miRNAs in hPHs ( Fig. 3A ; Supplementary Fig. S4A ). Three days posttransduction, qRT-PCR validated the expression of EHCC miRNAs (Fig.  3B) , and an MTT-based cellular proliferation assay was conducted to evaluate the proliferation-promoting capacity of these miRNAs. The MTT-based assay revealed a significant increase in hPHs in the EHCC miRNAexpressing conditions relative to the control (Fig. 3C) . Immunostaining with an antibody against a cell proliferation marker (Ki67) showed that hPHs transduced with lentivirus-expressing EHCC miRNAs possessed higher frequency of Ki67-positive cells relative to the control (Fig. 3D) . To exclude the possibility that the observed ). E, MTT assay shows 6 of 8 miRNAs that were identified to be commonly enriched in hESCs and HCCs (A) to possess a capacity to promote ESC self-renewal. F, transient knockdown of EHCC miRNAs in hESCs and HCC using antagomiRs hinders self-renewal and proliferation. For all statistical analyses, n ¼ 3 (for E, n ¼ 5), error bars represent SEM, the Student t-test results are indicated ( Ã , P < 0.05) relative to hESCs.
proliferation differences between the experimental and control conditions were caused by cell death, live/dead cell staining was conducted to show that the number of dead cells in both conditions were similar (Fig. 3E) . These findings indicate that stable expression of EHCC miRNAs in normally quiescent hPHs induces proliferation in vitro.
EHCC miRNAs suppress the translation of CDKN1A, PTEN, TGFBR2, and KLF11 In the proceeding sections ( Fig. 1A-E ; Tables 1 and 2 ), we have shown that depleting hESCs and HCCs of miRNAs through a transient knockdown of Dgcr8 leads to severe deficiency in self-renewal and proliferation. In addition, we have also shown that this deficiency is accompanied by the upregulation of genes possessing GO functional terms describing cell-cycle progression, suggesting that self-renewal and proliferation in hESCs and HCCs are promoted by miRNAs suppressing the expression of genes that negatively regulate cell-cycle progression. These observations led us to speculate whether a similar mechanism is used by EHCC miRNAs to induce proliferation in hPHs. To determine whether EHCC miRNAs suppress the translation of genes that inhibit cell-cycle progression in hPHs, we used an miRNA target prediction tool, Target Scan (www.targetscan.org; ref. 24) , to identify protein-coding genes with 3 0 UTR containing complementary target sites to EHCC miRNA seed sequences ( Fig. 2A) . Through this method, we identified 989 genes with 3 0 UTR regions possessing complementary sites to miR-106a, -106b, -17, and -93 and 723 genes with complementary sites to miR-301a and -130b. These gene sets were analyzed for GO functional terms, and the clusters of genes that were categorized under the term describing "negative regulation of cell proliferation" were selected for further analysis (Fig. 4A) . Among this list of gene set, 7 (Pten, Timp2, Tgfbr2, Klf11, Cdkn1a, Ereg, and Runx3) were identified to contain 3 0 UTR regions with putative target sites to all 6 EHCC miRNAs. Pten, Tgfbr2, Klf11, and Cdkn1a were then selected as potential targets of EHCC miRNAs because they are highly expressed in hPHs (Fig. 4B) .
To test the interaction potential of EHCC miRNAs and the 3 0 UTRs of Pten, Tgfbr2, Klf11, and Cdkn1a, luciferase reporter constructs were designed by fusing each of the 3 0 UTR elements immediately downstream of the luciferase reporter gene (Fig. 4C) . With the exception of miR-106b and Pten, all EHCC miRNAs significantly reduced luciferase expression (Fig. 4D) . Western blot assays of the total protein extracted from hPHs transduced with lentivirus-expressing EHCC miRNAs validated the direct translational suppression of Pten, Tgfbr2, Klf11, and Cdkn1a by most of the EHCC miRNAs (Fig. 4E) . As observed using the luciferase expression assay, the Western blot assay also showed that miR-106b does not appear to directly suppress PTEN. Unlike the luciferase expression assay, however, the Western blot assay did not show a significant of protein expression in the Cdkn1a/miR-17, Cdkn1a/miR-301a, Tgfbr2/miR106a, and Tgfbr2/miR-106b gene/miR combinations compared with the control. This discrepancy between the 2 methods of assay may be attributable to the qualitative nature of the Western blot assay. Not surprisingly, Figure 4 . EHCC miRNAs directly suppress the translation of Cdkn1a, Pten, Tgfbr2, and Klf11 in hPHs. A, an miRNA target prediction tool, Target Scan, was used to identify mRNAs with 3 0 UTR region predicted to be targeted by either of the 2 EHCC miRNA seed sequences ( Fig. 2A) . These genes were analyzed for GO terms, and the terms associated with cell-cycle regulation are listed in the first column. Among the list of GO terms associated with cell-cycle regulation, "negative regulation of cell proliferation" is boxed in blue, and the identity of genes that make up this category are listed in the second column. The last column boxed in blue and filled in orange lists 7 genes that are predicted to be targeted by all EHCC miRNAs. B, the heatmap shows the expression pattern and hierarchical clustering of the 7 genes in hESCs, HCCs, and hPHs. Among this list of genes, Pten, Tgfbr2, Klf11, and Cdkn1a are highly expressed in hPHs. iPS, induced pluripotent stem cells. C, a map of the luciferase reporter construct. The luciferase reporter construct shows that the 3 0 UTR (red) elements are inserted immediately downstream of the firefly luciferase gene (blue), which is under the control of a constitutive cytomegalovirus (CMV) promoter (black). Downstream of the MRE (miRNA response element) insert is the polyadenylation signal (pA; gray). The genomic positions of the 3 0 UTR regions of Pten, Tgfbr2, Klf11, and Cdkn1a are listed in the table. The table also shows the target sites of miR-106a, -106b, -17, and -93 in green, and miR-301a and -130b in yellow. D, the luciferase reporter constructs with the 3 0 UTR inserts validate the interaction of the EHCC miRNAs with CDKN1A, TGFBR2, and KLF11. For PTEN, all EHCC miRNAs except miR-106b directly interact with the 3 0 UTR of this gene. Each luciferase construct was cotransfected into mESC Dgcr88/Dgcr8 with miR mimics or mock miR mimics, and Renilla luciferase construct as a normalization control. The luciferase activity was assayed 36 hours after transfection. For all statistical analyses, n ¼ 5, error bars represent SEM, the Student t-test results are indicated ( Ã , P < 0.05) relative to the control. E, Western blot assay of hPHs that were transduced with lentivirus-mediated expression of a mock control miRNA, individual EHCC miRNAs, or all EHCC miRNAs combined. The protein sizes are listed on the far right column. expression of all 6 EHCC miRNAs combined led to the greatest reduction of PTEN, TGFBR2, KLF11, and CDKN1A endogenous protein levels in hPHs. These findings suggest that one possible mechanism by which EHCC miRNAs induce proliferation in hPHs is by suppressing the translation of genes with GO functional descriptions involving negative regulation of cellular proliferation.
EHCC miRNAs activate cancer signaling pathways in hPHs
The literature describes PTEN, TGFBR2, and KLF11 as important tumor suppressors that are frequent dysregulated in cancer and highly correlated with disease progression and prognosis in clinical hepatocellular carcinomas (25) (26) (27) . We thus asked whether direct translational suppression of Cdkn1a, Pten, Tgfbr2, and Klf11 by EHCC miRNAs may alter the cellular programming to activate cancer signaling pathways. Global gene expression analysis following lentivirus-mediated expression of EHCC miRNAs in hPHs revealed only a minor perturbance, with the lowest Pearson correlation coefficient value at r 2 ¼ 0.9440 ( Supplementary Fig. S5A-S5G ). Strikingly however, DAVID's KEGG pathway analysis tool revealed that the functional properties of these small fraction of deregulated genes are frequently implicated in a multitude of cancer pathways (28) (29) (30) , such as DNA replication, p53, mTOR, TGFb, as well as various cancer malignancy (e.g., colorectal cancer, prostate cancer, acute myeloid leukemia, renal cell carcinoma, pancreatic cancer; Tables 3 and 4; Supplementary Table S1 ). Because Pten, Tgfbr2, Klf11, and Cdkn1a have been reported to play pivotal mediatory roles in PTEN/PIP3/PKB/AKT/ mTOR and TGFb tumor suppressor signaling pathways (29, 31) , it is possible that direct translational suppression of these genes by EHCC miRNAs may trigger the dysregulation of these signaling pathways (Fig. 5A) . Unlike in hPHs, highly enriched genes in hESCs are not associated with KEGG cancer-associated genes (Supplementary  Table S2 ). Moreover, lentivirus-mediated expression of EHCC miRNAs in hPHs does not increase the expression of hESC-associated genes (e.g., Pou5f1, Nanog, Sox2), nor hepatic progenitor-associated genes (e.g., Afp), suggesting that these miRNAs are not capable of reprogramming differentiated hPHs into pluri-or multipotent stem celllike state ( Fig. 5B; Supplementary Fig. S6 ). These observations suggest the critical importance of monitoring the loss of EHCC miRNAs in hepatic derivatives of hESCs, because while these miRNAs are beneficial to hESCs for maintaining "stemness," their continued expression in hepatic derivatives may render the cells with neoplastic transformation potential.
EHCC miRNAs induce EMT in hPHs
To examine the long-term effect of EHCC miRNAs on hPHs, the cells were cultured for 15 days following the transduction of lentivirus-mediated expression of these miRNAs. At this time point, we observed a significant morphologic difference between hPHs that were transduced with lentivirus-expressing EHCC miRNAs and mock control miRNAs. Consistent with the literature (2), most hPHs transduced with mock control miRNAs died within several days after the isolation procedure from the liver (Fig. 5C, first  column) . In contrast, the culture condition in which hPHs have been transduced with lentivirus-expressing EHCC miRNAs appeared to contain higher number of hepatocytes relative to the control, and a large fraction of these cells appeared to have dedifferentiated into fibroblast-like cells having lost cell adhesion and undergoing rapid proliferation (Fig. 5C, middle column) . In addition, a fraction of these hPHs were observed to have mobilized into clusters of tumor-like spheroids (Fig. 5C, last column) . Both loss of cell adhesion and increased cell mobility have been described as characteristic features of EMT (32) . While EMT has been described as an essential mechanism during numerous developmental processes, induction of EMT has also been implicated in the onset and progression of metastatic cancer cells. In recent years, reports have postulated a link between the activation of PI3K/AKT signaling pathway and the induction of EMT during carcinogenesis (33) . Having shown that EHCC miRNAs activate the PI3K/PKB/Akt/ mTOR signaling pathway through direct translational suppression of Pten, we sought to examine whether loss of cell adhesion and gain of proliferation and mobilization functions in hPHs expressing EHCC miRNAs may, at least partially, be caused by the induction of EMT. To examine this possibility, we conducted Western blot analysis on hPHs 3 days following the transduction of lentivirus mediating the expression of EHCC miRNAs using antibodies to detect EMT. We found the endogenous levels of epithelial cellassociated proteins such as E-cadherin, claudin-1 and ZO-1 to be generally downregulated in hPH-expressing EHCC miRNAs relative to control and upregulation of several proteins that have been reported to be associated with mesenchymal cells (Fig. 5D ). These findings suggest that aberrant expression of EHCC miRNAs in hPHs in vitro may initiate the onset of features described in EMT.
EHCC miRNAs are upregulated in human liver tumor tissues Because established cell lines cannot fully infer clinical malignancy, we used qRT-PCR to assay for the expression levels of EHCC miRNAs in human liver tumor tissues. In these tissue samples, we found that various combinations of EHCC miRNAs are elevated, relative to their normal tissue counterparts (Fig. 5E ). These observations indicate miRNAs that possess a capacity to promote ESC self-renewal are frequently upregulated in liver cancer and that proper attenuation of their expression in differentiated hepatocytes may be critical for avoiding harmful consequences for the cell.
Discussion
In this study, we have provided evidence to show that a common network of miRNAs regulates ESC self-renewal, as well as HCC proliferation, and that reexpression of these miRNAs in normally quiescent hPHs induces proliferation and activates genes involved in cancer signaling pathways. These findings suggest that miRNAs that play a critical role in normal development as promoters of ESC self-renewal possess neoplastic transformation potential when they escape silencing in hepatic derivatives of hESCs. An examination of perturbed gene expression patterns following the introduction of these miRNAs in hPHs uncovered their involvement as potent inhibitors of tumor suppressors that mediate the repression of the PI3K/PKB/Akt/mTOR and stimulation of the TGFb signaling pathways. In a multitude of cancer cells, aberrant activation of the PI3K/PKB/Akt/mTOR pathway has been implicated in uncontrolled growth and cell death evasion, whereas the loss of TGFb signaling has been observed in cancer cells having lost the ability to initiate cell-cycle arrest (29) . Furthermore, we showed that aberrant expression of these miRNAs in hPHs leads to EMT, suggesting the potential of these miRNAs to transform normal hepatocytes into neoplastic cells. Taken together, our findings highlight the critical importance of monitoring the silencing of miRNAs that function as promoters of ESC self-renewal in hepatic derivatives of hESCs.
In the model we propose (Fig. 5A) , EHCC miRNAs espouse an oncogene-like function in differentiated hPHs by directly suppressing the translation of tumor suppressors that regulate cellular proliferation. By suppressing the translation of Tgfbr2 and Klf11, EHCC miRNAs repress the TGFb signaling pathway. Studies have shown that TGFb is a multifunctional cytokine which controls a plethora of cellular events, including proliferation, because of its ability to inhibit G 1 -S-phase cell-cycle transition through the activation cell-cycle-regulating kinases (30) and coactivators (34) . Because both TGFBR2 and KLF11 function as positive mediators of the TGFb signaling pathway, suppressing the translation of these proteins by EHCC miRNAs may lead to the inhibition of TGFb-induced cell-cycle arrest (35, 36) . In addition to the suppression of the TGFb signaling pathway, we showed that EHCC miRNAs may control the activation of proliferation in hPHs by activating the PI3K/PKB/Akt/ mTOR pathway through direct translational suppression of Pten and Cdkn1a. In many solid tumors, including hepatocellular carcinomas, stimulation of the PI3K/PKB/Akt/ mTOR pathway has been described as a major determinant of growth and survival because of its pivotal role as an enhancer of proliferation and apoptotic resistance (28, 29, 37, 38) . Because the PI3K/PKB/Akt/mTOR pathway is negatively regulated by PTEN in normal tissues (39) , translational suppression of Pten by EHCC miRNAs may lead to the activation of this signaling pathway in hPHs. Hence, by suppressing key mediators of the TGFb and the PI3K/PKB/Akt/mTOR signaling pathways, EHCC miRNAs effectively dysregulate these signaling pathways that have been frequently described in the literature to be implicated in cancer (29) .
Because EHCC miRNAs directly suppress key tumor suppressor genes in cellular signaling pathways that have been reported in the literature to be implicated in many different types of carcinogenesis, we examined an exemplary sample of published reports to evaluate whether these miRNAs are upregulated in cancer cell lines and tumor tissues other than HCCs. We found that miR-106a and miR-17 are frequently upregulated in hematology, colon, and melanoma cancer cell lines (40) , as well as various types of solid tumors from breast, colon, lung, pancreas, and prostate tissues (41) . Likewise, miR-106b has been implicated in gastric and prostate carcinoma proliferation (42, 43) , miR-301a has been reported as an activator of NF-kB leading to pancreatic tumor growth (44) , miR-130b has been identified as an active promoter of liver tumor growth Figure 5 . EHCC miRNAs activate cancer signaling pathways and induce EMT in hPHs. A, the diagram shows the potential effect of EHCC miRNAs on PTEN and TGFb signaling pathways. EHCC miRNAs are boxed in red. PI3K, phosphoinositide 3-kinase. B, qRT-PCR analysis of pluripotent ESC markers in hPHs transduced with lentivirus-expressing EHCC miRNAs relative to control. C, images show hPHs that have been transduced with lentivirus constitutively expressing EHCC miRNAs (miR-106a/106b/17/93/301a/130b) or a mock control miRNA (control) 17 days after the cells were isolated from the liver. The first column shows that hPHs transduced with control miRNAs. The second and third columns show that hPHs have been transduced with lentivirus-expressing EHCC miRNAs. D, Western blot assay of hPHs transduced with lentivirus-mediated expression of a mock control miRNA, individual EHCC miRNAs, or all EHCC miRNAs combined. The total protein was extracted from hPHs 3 days after the cells were transduced with lentivirus-expressing EHCC miRNAs (Supplementary Fig. S3 ). Antibodies used for protein detection are reported to be associated with EMT. Protein sizes are listed in the far right column. E, qRT-PCR analysis of EHCC miRNA expression in human liver tumor samples relative to their normal tissue counterparts. For all statistical analyses, qRT-PCR was carried out in triplicates, error bars represent SEM, and the Student t-test results are indicated ( Ã , P < 0.05) relative to the control. (45) , and miR-17-92 cluster has been shown to be overexpressed in various cancer types (46) . In view of these reports, perhaps it is not surprising that these miRNAs are highly upregulated in HCCs and play an active role as facilitators of proliferation. However, it is striking that not a single report to date has shown that these 6 miRNAs are also critical for normal development as promoters of hESC self-renewal. Our study has thus shown for the first time that miRNAs that hold an essential for one of the hallmark traits of hESCs are upregulated in HCCs and that a failure to silence their expression in normal-differentiated quiescent cell type such as hepatocytes may potentially lead to neoplastic transformation.
In summary, our study has shown that tracking the loss of EHCC miRNA expression in hepatic derivatives of hESCs in vitro is critical for assessing the translational potential of hESCs for therapeutic applications. It is likely that miRNAs in addition to the ones described in this study are involved in promoting ESC self-renewal while also possessing a capacity for activating cancer signaling pathways in normal hepatocytes. For example, it would be important to examine whether hESC-specific miRNAs such as the miR-302/ 367 cluster, that we did not find upregulated in HCCs, may also be involved in activating cancer pathways in normal hPHs when they escape silencing. By focusing on miRNAs that are commonly enriched in hESCs and HCCs, we present a rationale and a practical approach, as an example, for determining whether miRNAs that play an essential in normal development as promoters of ESC self-renewal are pervasively upregulated in liver cancer cells and whether these miRNAs harbor neoplastic transformation potential when they escape silencing in normally quiescent hepatocytes.
Further studies are needed to examine whether EHCC miRNAs are silenced in hepatic derivatives of hESCs in an in vitro culture system, and also, the tumor-forming potential of these cells needs to be evaluated in vivo.
These are relevant concerns because markers for fetal rather than mature hepatocytes, such as a-fetoprotein (AFP), that are also highly expressed in HCCs, are persistently expressed in hepatocytes derived from hESCs in an in vitro culture system (4). In-depth analyses are hampered at present by the lack of experimental strategy for isolating and culturing hepatic derivatives from differentiated hESCs in in vitro culture (2) . An efficient method to stably introduce reporter genes in hESCs, and targeted knockout of individual miRNAs in hESCs would greatly facilitate this endeavor. An enhanced understanding of molecular mechanisms underlying the regulation of ESC self-renewal, as well as cancer cell proliferation, is critical if hESCs are to be used in regenerative medicine. In this study, we have taken a small step in this direction by describing the neoplastic transformation potential of miRNAs that are essential for hESC self-renewal when they escape proper attenuation in quiescent hepatocytes.
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